A Comparison of Methodologies for Estimating Survival in Patients Treated with Second-generation Tyrosine-kinase Inhibitors (TKIs) for Chronic Myeloid Leukaemia (CML)
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.023
https://www.valueinhealthjournal.com/article/S1098-3015(13)01928-1/fulltext
Title :
A Comparison of Methodologies for Estimating Survival in Patients Treated with Second-generation Tyrosine-kinase Inhibitors (TKIs) for Chronic Myeloid Leukaemia (CML)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)01928-1&doi=10.1016/j.jval.2013.08.023
First page :
A326
Section Title :
Research on Methods – Clinical Studies
Open access? :
No
Section Order :
17